{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T10:13:26Z","timestamp":1777198406427,"version":"3.51.4"},"reference-count":31,"publisher":"Japanese Circulation Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2022,8,25]]},"DOI":"10.1253\/circj.cj-22-0098","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T22:10:22Z","timestamp":1654294222000},"page":"1397-1408","source":"Crossref","is-referenced-by-count":14,"title":["Comparison of 1-Month and 12-Month Vessel Responses Between the Polymer-Free Biolimus A9-Coated Stent and the Durable Polymer Everolimus-Eluting Stent"],"prefix":"10.1253","volume":"86","author":[{"given":"Takayuki","family":"Ishihara","sequence":"first","affiliation":[{"name":"Kansai Rosai Hospital Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isamu","family":"Mizote","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotaka","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka Rosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Shiraki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Itaya","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Kurume University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Tsujimura","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Takahara","sequence":"additional","affiliation":[{"name":"Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaharu","family":"Nakayoshi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Kurume University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Iida","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Hata","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Nishino","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka Rosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Ueno","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Fukuoka Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisaku","family":"Nakatani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shungo","family":"Hikoso","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Nanto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nishinomiya Municipal Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Mano","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The COLLABORATION Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. <i>N Engl J Med<\/i> 2002; 346: 1773\u20131780.","DOI":"10.1056\/NEJMoa012843"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. <i>Lancet<\/i> 2004; 364: 1519\u20131521.","DOI":"10.1016\/S0140-6736(04)17275-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: An update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. <i>Circulation<\/i> 2016; 134: e123\u2013e155.","DOI":"10.1161\/CIR.0000000000000404"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). <i>Eur Heart J<\/i> 2018; 39: 213\u2013260.","DOI":"10.1093\/eurheartj\/ehx638"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nakamura M, Kimura K, Kimura T, Ishihara M, Otsuka F, Kozuma K, et al. JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease. <i>Circ J<\/i> 2020; 84: 831\u2013865.","DOI":"10.1253\/circj.CJ-19-1109"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tada N, Virmani R, Grant G, Bartlett L, Black A, Clavijo C, et al. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model. <i>Circ Cardiovasc Interv<\/i> 2010; 3: 174\u2013183.","DOI":"10.1161\/CIRCINTERVENTIONS.109.877522"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Urban P, Meredith IT, Abizaid A, Pocock SJ, Carri\u00e9 D, Naber C, et al. Polymer-free drug-coated coronary stents in patients at high bleeding risk. <i>N Engl J Med<\/i> 2015; 373: 2038\u20132047.","DOI":"10.1056\/NEJMoa1503943"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Jinnouchi H, Otsuka F, Sato Y, Bhoite RR, Sakamoto A, Torii S, et al. Healthy strut coverage after coronary stent implantation: An ex vivo human autopsy study. <i>Circ Cardiovasc Interv<\/i> 2020; 13: e008869.","DOI":"10.1161\/CIRCINTERVENTIONS.119.008869"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Garg S, Serruys PW. Coronary stents: Current status. <i>J Am Coll Cardiol<\/i> 2010; 56: S1\u2013S42.","DOI":"10.1016\/j.jacc.2010.06.007"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Eisenstein EL, Leon MB, Kandzari DE, Mauri L, Edwards R, Kong DF, et al. Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized controlled trial of the Medtronic Endeavor drug [ABT-578] eluting coronary stent system versus the cypher sirolimus-eluting coronary stent system in de novo native coronary artery lesions). <i>JACC Cardiovasc Interv<\/i> 2009; 2: 1199\u20131207.","DOI":"10.1016\/j.jcin.2009.10.009"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mitsutake Y, Ueno T, Yokoyama S, Sasaki K, Sugi Y, Toyama Y, et al. Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents. <i>J Am Coll Cardiol Intv<\/i> 2012; 5: 966\u2013973.","DOI":"10.1016\/j.jcin.2012.06.010"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Awata M, Kotani J, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: Comparison with bare-metal stents. <i>Circulation<\/i> 2007; 116: 910\u2013916.","DOI":"10.1161\/CIRCULATIONAHA.105.609057"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ishihara T, Awata T, Sera F, Fujita M, Watanabe T, Iida O, et al. Arterial repair 4 months after zotarolimus-eluting stent implantation observed on angioscopy. <i>Circ J<\/i> 2013; 77: 1186\u20131192.","DOI":"10.1253\/circj.CJ-12-1369"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Dai K, Matsuoka H, Kawakami H, Sato T, Watanabe K, Nakama Y, et al. Comparison of chronic angioscopic findings of bare metal stents, 1st-generation drug-eluting stents and 2nd-generation drug-eluting stents: Multicenter study of intra-coronary angioscopy after stent (MICASA). <i>Circ J<\/i> 2016; 80: 1916\u20131921.","DOI":"10.1253\/circj.CJ-16-0121"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Suzuki N, Asano T, Nakazawa G, Aoki J, Tanabe K, Hibi K, et al. Clinical expert consensus document on quantitative coronary angiography from the Japanese Association of Cardiovascular Intervention and Therapeutics. <i>Cardiovasc Interv Ther<\/i> 2020; 35: 105\u2013116.","DOI":"10.1007\/s12928-020-00653-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, et al. Incomplete neointimal coverage of sirolimus-eluting stents: Angioscopic findings. <i>J Am Coll Cardiol<\/i> 2006; 47: 2108\u20132111.","DOI":"10.1016\/j.jacc.2005.11.092"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ishihara T, Tsujimura T, Okuno S, Iida O, Asai M, Masuda M, et al. Early- and middle-phase arterial repair following bioresorbable- and durable-polymer drug-eluting stent implantation: An angioscopic study. <i>Int J Cardiol<\/i> 2019; 285: 27\u201331.","DOI":"10.1016\/j.ijcard.2019.02.059"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mitsutake Y, Yano H, Ishihara T, Matsuoka H, Ueda Y, Ueno T. Consensus document on the standard of coronary angioscopy examination and assessment from the Japanese Association of Cardiovascular Intervention and Therapeutics. <i>Cardiovasc Interv Ther<\/i> 2022; 37: 35\u201339.","DOI":"10.1007\/s12928-021-00770-x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Saito S, Krucoff MW, Nakamura S, Mehran R, Maehara A, Al-Khalidi HR, et al. Japan-United States of America harmonized assessment by randomized multicentre study of OrbusNEich\u2019s Combo StEnt (Japan-USA HARMONEE) study: Primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome. <i>Eur Heart J<\/i> 2018; 39: 2460\u20132468.","DOI":"10.1093\/eurheartj\/ehy275"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tada T, Kadota K, Hosogi S, Miyake K, Amano H, Nakamura M, et al. Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: A comparison with plain old balloon angioplasty. <i>Eur Heart J Cardiovasc Imaging<\/i> 2014; 15: 307\u2013315.","DOI":"10.1093\/ehjci\/jet165"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nakamura D, Attizzani GF, Toma C, Sheth T, Wang W, Soud M, et al. Failure mechanisms and neoatherosclerosis patterns in very late drug eluting and bare-metal stent thrombosis. <i>Circ Cardiovasc Interv<\/i> 2016; 9: e003785.","DOI":"10.1161\/CIRCINTERVENTIONS.116.003785"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nakamura D, Lee Y, Yoshimura T, Taniike M, Makino N, Kato H, et al. Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: An optical coherence tomographic study. <i>EuroIntervention<\/i> 2014; 10: 924\u2013933.","DOI":"10.4244\/EIJV10I8A159"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nakamura D, Dohi T, Ishihara T, Kikuchi A, Mori N, Yokoi K, et al. Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis. <i>EuroIntervention<\/i> 2020; 17: 489\u2013496.","DOI":"10.4244\/EIJ-D-20-00539"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Okuno S, Ishihara T, Iida O, Asai M, Masuda M, Okamoto S, et al. Association of subclinical intrastent thrombus detected 9 months after implantation of 2nd-generation drug-eluting stent with future major adverse cardiac events: A coronary angioscopic study. <i>Circ J<\/i> 2018; 82: 2299\u20132304.","DOI":"10.1253\/circj.CJ-18-0098"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nakazawa G. Stent thrombosis of drug eluting stent: Pathological perspective. <i>J Cardiol<\/i> 2011; 58: 84\u201391.","DOI":"10.1016\/j.jjcc.2011.07.004"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Sabat\u00e9 M, Okkels Jensen L, Tilsted HH, Moreno R, Garc\u00eda Del Blanco B, Macaya C, et al. Thin- versus thick-strut polymer-free biolimus-eluting stents: The BioFreedom QCA randomised trial. <i>EuroIntervention<\/i> 2021; 17: 233\u2013239.","DOI":"10.4244\/EIJ-D-20-01162"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, et al. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: The STOPDAPT-2 Randomized Clinical Trial. <i>JAMA<\/i> 2019; 321: 2414\u20132427.","DOI":"10.1001\/jama.2019.8145"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Serruys PW, Suwannasom P, Nakatani S, Onuma Y. Snowshoe versus ice skate for scaffolding of disrupted vessel wall. <i>J Am Coll Cardiol Intv<\/i> 2015; 8: 910\u2013913.","DOI":"10.1016\/j.jcin.2015.04.005"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kolandaivelu K, Swaminathan R, Gibson WJ, Kolachalama VB, Nguyen-Ehrenreich KL, Giddings VL, et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. <i>Circulation<\/i> 2011; 123: 1400\u20131409.","DOI":"10.1161\/CIRCULATIONAHA.110.003210"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Pache J, Kastrati A, Mehilli J, Sch\u00fchlen H, Dotzer F, Hausleiter J, et al. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. <i>J Am Coll Cardiol<\/i> 2003; 41: 1283\u20131288.","DOI":"10.1016\/S0735-1097(03)00119-0"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Madhavan MV, Howard JP, Naqvi A, Ben-Yehuda O, Redfors B, Prasad M, et al. Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: A systematic review and meta-analysis of randomized controlled trials. <i>Eur Heart J<\/i> 2021; 42: 2643\u20132654.","DOI":"10.1093\/eurheartj\/ehab280"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/86\/9\/86_CJ-22-0098\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T04:44:48Z","timestamp":1661575488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/86\/9\/86_CJ-22-0098\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-22-0098","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"article-number":"CJ-22-0098"}}